Jpmorgan Chase & CO Puma Biotechnology, Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 48,352 shares of PBYI stock, worth $176,001. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,352

Previous 136,897 64.68%

Holding current value

$176,001

Previous $417,000 65.71%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$2.76 - $3.88 $244,384 - $343,554	-88,545 Reduced 64.68%	48,352 $143,000
Q4 2024 Feb 12, 2025	BUY	$2.42 - $3.39 $213,937 - $299,689	88,404 Added 182.3%	136,897 $417,000
Q3 2024 Dec 26, 2024	BUY	$2.25 - $4.03 $68,622 - $122,910	30,499 Added 169.5%	48,493 $123,000
Q3 2024 Nov 08, 2024	BUY	$2.25 - $4.03 $68,622 - $122,910	30,499 Added 169.5%	48,493 $123,000
Q2 2024 Dec 26, 2024	SELL	$2.92 - $5.83 $89,057 - $177,809	-30,499 Reduced 62.89%	17,994 $58,000
Q2 2024 Aug 12, 2024	SELL	$2.92 - $5.83 $35,647 - $71,172	-12,208 Reduced 40.42%	17,994 $58,000
Q1 2024 Dec 26, 2024	SELL	$4.29 - $7.4 $78,468 - $135,353	-18,291 Reduced 37.72%	30,202 $160,000
Q1 2024 May 10, 2024	BUY	$4.29 - $7.4 $12,904 - $22,259	3,008 Added 11.06%	30,202 $160,000
Q4 2023 Dec 26, 2024	SELL	$2.23 - $4.49 $47,496 - $95,632	-21,299 Reduced 43.92%	27,194 $117,000
Q4 2023 Feb 12, 2024	BUY	$2.23 - $4.49 $60,511 - $121,836	27,135 Added 45991.53%	27,194 $117,000
Q3 2023 Nov 14, 2023	SELL	$2.63 - $4.09 $2,745 - $4,269	-1,044 Reduced 94.65%	59 $0
Q4 2022 Feb 13, 2023	SELL	$2.12 - $5.08 $3,701 - $8,869	-1,746 Reduced 61.28%	1,103 $5,000
Q3 2022 Nov 14, 2022	BUY	$2.27 - $3.84 $1,400 - $2,369	617 Added 27.64%	2,849 $7,000
Q2 2022 Aug 11, 2022	SELL	$1.64 - $3.3 $230,664 - $464,141	-140,649 Reduced 98.44%	2,232 $6,000
Q1 2022 May 11, 2022	SELL	$2.13 - $3.24 $1,312 - $1,995	-616 Reduced 0.43%	142,881 $412,000
Q4 2021 Feb 10, 2022	SELL	$2.85 - $6.58 $15,512 - $35,814	-5,443 Reduced 3.65%	143,497 $437,000
Q3 2021 Nov 12, 2021	BUY	$6.63 - $9.39 $987,472 - $1.4 Million	148,940 New	148,940 $1.04 Million

Others Institutions Holding PBYI

# of Institutions

116

Shares Held

30.9M

Call Options Held

32.7K

Put Options Held

200

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $166M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Puma Biotechnology, Inc. Transaction History